Zobrazeno 1 - 4
of 4
pro vyhledávání: '"HuaGuo Wu"'
Autor:
Hui Zhang, Yong Wang, Huaguo Wu, Shizhen Zhou, Shuo Li, Xiangji Meng, Rongjie Tao, Jinming Yu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Lung cancer patients with brain and leptomeningeal metastases usually have poor prognosis. For those patients with EGFR mutations, osimertinib, a third-generation tyrosine kinase inhibitor (TKI), is the first choice of treatment. However, drug resist
Externí odkaz:
https://doaj.org/article/9fcb894caf0a4f55b72856ffc53c9c39
Autor:
Zhiwei Hou, Huaguo Wu, Ningning Luo, Shuo Li, Xiang Zhang, Shuai Dong, Dongyuan Zhu, Hui Zhang, Rongjie Tao
Publikováno v:
The Oncologist. 28:449-452
Glioblastoma (GBM) is the most common primary brain tumor, and patients with GBM have a universally poor prognosis. Genomic profiling has detected epidermal growth factor receptor (EGFR) gene alterations in more than half of GBMs. Major genetic event
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e683f040eca0ec0c0b7d057f725a7f3b
https://doi.org/10.1093/oncolo/oyac280
https://doi.org/10.1093/oncolo/oyac280
Autor:
Zhiwei Hou1, Long Lai1, HuaGuo Wu1, Benkui Zou1, Ni Xu1, Dongyuan Zhu1, Xiaokun Wang1, Hui Zhang1 hui8942615@163.com
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 14, p4527-4533. 7p.
Publikováno v:
Recent patents on anti-cancer drug discovery. 16(1)
Background: Diagnosis of Leptomeningeal Metastases (LM) from Non-Small Cell Lung Cancer (NSCLC) is usually based on clinical symptoms, Cerebral-Spinal Fluid (CSF) cytology, and neuro-imaging. However, early diagnosis of LM in NSCLC is challenging due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98bfdcea1123333049525760092e3e1e
https://pubmed.ncbi.nlm.nih.gov/33245275
https://pubmed.ncbi.nlm.nih.gov/33245275